Coexpression of HER3 as a predictor of survival in HER2-positve breast cancer patients.
Rupert Bartsch(Universitätszahnklinik Wien), Christoph Zielinski(Vienna General Hospital), Anna S. Berghoff(Medical University of Vienna), Guenther G. Steger(Mount Vernon Hospital), Matthias Preusser(Medical University of Vienna), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Peter Birner(Medical University of Vienna), M. Rudas(Comprehensive Cancer Center Vienna)
Cited by 3
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
|Journal of Clinical Oncology|2010|1.6k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k